Saudi German Health net profit projected to decline in Q3 2021

31/10/2021 Argaam Exclusive

In this report, Argaam captures the expected results of Middle East Healthcare Co. (Saudi German Health) during the third quarter of 2021, in addition to key events, development of sales and quarterly revenue, in addition to performance and profitability indicators.

 

The third-quarter revenue is projected to rise 2.47% year-on-year (YoY) to SAR 504.30 million.

Quarter Revenue Changes (M Riyal)

Item Q3
2020		 Q4
2020		 Q1
2021		 Q2
2021		 Q3
2021
(Average Estimate)
Sales 492.13 448.89 418.37 456.57 504.30
Change % 27.25% 10.42% (4.11%) 22.32% 2.47%

Quarter Net Income Changes (M Riyal)

Item Q3
2020		 Q4
2020		 Q1
2021		 Q2
2021		 Q3
2021
(Average Estimate)
Net Income 34.91 9.54 12.10 9.14 32.55
Extraordinary income/expense 0.00 0.00 17.53 (0.48) -
Net Profit Before Unusual Items 34.91 9.54 (5.43) 9.62 -
EPS Before Unusual Items (Riyal/Share) 0.38 0.10 (0.06) 0.10 0.35

Key events during Q3 2021:

 

The company agreed with Al Sobh New Medical Co., a related party that owns Sobhi Abdul Jalil Batterjee Medical Hospital, to extend a memorandum of understanding (MoU) to enter as an investor partner in the hospital for an additional 90 business days.

 

The company resumed the contractual relationship with The Company for Cooperative Insurance (Tawuniya) since early July 2021. The company's financial results are expected to be positively impacted during the quarter.

Quarterly Profit and Revenue (M Riyal)

Average forecasts

 

The company is projected to report a net profit of SAR 32.55 million for Q3 2021, a decrease of 6.77% YoY, according to the average estimates by two research firms.

Quarterly Actuals vs Estimates (M Riyal)

Average Estimate (M Riyal)

Analyst Million Riyals
SNB Capital Company 36.00
AlJazira Capital Company 29.10
Average 32.55
Net Profit Before Unusual Items (2020 - Q3) 34.91
Change % (6.77%)

P/E (TTM)

Stock Performance

Item The Company TASI
YTD (2.60 %) 35.89 %
Change(12M) 23.21 % 48.82 %
Previous Close 37.25 11,704.14
P/E adjusted (x) More than 100 24.20
EPS (TTM) before unusual items (SAR/Share) 0.53 -
Middle East Healthcare Co.
86.00
(0.90) (1.04 %)

Valuation Data (Latest Share Price)

P/E (TTM) 43.49
P/E Before Unusual Items (TTM) 43.49
P/BV 5.03
Dividend Yield 0.00 %
Market Cap. (M) 7,915.44
Return on Average Assets 3.76 %
Return on Average Equity 12.19 %

Most Read

ajax loading

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.